Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • Patients
    • Obefazimod for UC
    • Obefazimod for Crohn’s
    • Obefazimod for RA
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • General Meeting
  • Contact Us
  • ECCO 2022
Search
  • EN
  • FR
  • DE

News & Events

Press Coverage

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018

Les Echos investir

December 28, 2019

A potential target

DER AKTIONÄR

December 18, 2019

Biotech secret tip Abivax: Up more than 100% in just two months – will this trend continue?

Edison Investment Research

December 13, 2019

Executive interview with Abivax CEO and CFO at the EKF conference 2019

DER AKTIONÄR

December 4, 2019

Biotech secret tip Abivax Takes off: Monster target price – a share for 2020?

Empowered Patient Podcast

June 5, 2019

Unique Therapy for Multiple Inflammatory Diseases with Dr. Jean-Marc Steens Abivax

  • 1
  • 2
© 2023 All rights reserved by ABIVAX | Website created by Stratégie et communication digitale : JLL CONSEIL Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Obefazimod for UC
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • General Meeting
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+